Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Cancer chemotherapy and pharmacology

Results: 1-25/119

Authors: HASSAN M OBERG G BJORKHOLM M WALLIN I LINDGREN M
Citation: M. Hassan et al., INFLUENCE OF PROPHYLACTIC ANTICONVULSANT THERAPY ON HIGH-DOSE BUSULFAN KINETICS, Cancer chemotherapy and pharmacology, 33(3), 1993, pp. 181-186

Authors: KIM T KIM J KIM S
Citation: T. Kim et al., EXTENDED-RELEASE FORMULATION OF MORPHINE FOR SUBCUTANEOUS ADMINISTRATION, Cancer chemotherapy and pharmacology, 33(3), 1993, pp. 187-190

Authors: GAO JP FRIEDMAN S LANKS KW
Citation: Jp. Gao et al., THE ROLE OF REDUCED NICOTINAMIDE ADENINE-DINUCLEOTIDE PHOSPHATE IN GLUCOSE-DEPENDENT AND TEMPERATURE-DEPENDENT DOXORUBICIN CYTOTOXICITY, Cancer chemotherapy and pharmacology, 33(3), 1993, pp. 191-196

Authors: AVRAMIS VI CHAN KK SOLORZANO MM CHEN ZL
Citation: Vi. Avramis et al., PRECLINICAL PHARMACOLOGY OF THE ANTITUMOR AGENT O-6-METHYLGUANINE IN CDF1 MICE, Cancer chemotherapy and pharmacology, 33(3), 1993, pp. 197-202

Authors: VOKES EE HARAF DJ HOFFMAN PC
Citation: Ee. Vokes et al., ESCALATING DOSES OF INTERFERON ALPHA-2A WITH CISPLATIN AND CONCOMITANT RADIOTHERAPY - A PHASE-I STUDY, Cancer chemotherapy and pharmacology, 33(3), 1993, pp. 203-209

Authors: WAN XS STCLAIR DK
Citation: Xs. Wan et Dk. Stclair, DIFFERENTIAL CYTOTOXICITY OF BUTHIONINE SULFOXIMINE TO NORMAL AND TRANSFORMED HUMAN LUNG FIBROBLAST CELLS, Cancer chemotherapy and pharmacology, 33(3), 1993, pp. 210-214

Authors: LEE JH NAITO M NAKAJIMA M TSURUO T
Citation: Jh. Lee et al., ISOLATION AND CHARACTERIZATION OF A MITOMYCIN-C-RESISTANT VARIANT OF HUMAN COLON-CARCINOMA HT-29 CELLS, Cancer chemotherapy and pharmacology, 33(3), 1993, pp. 215-220

Authors: BJARNASON GA KERR IG DOYLE N MACDONALD M SONE M
Citation: Ga. Bjarnason et al., PHASE-I STUDY OF 5-FLUOROURACIL AND LEUCOVORIN BY A 14-DAY CIRCADIAN INFUSION IN METASTATIC ADENOCARCINOMA PATIENTS, Cancer chemotherapy and pharmacology, 33(3), 1993, pp. 221-228

Authors: TEICHER BA SOTOMAYOR EA HUANG ZD ARA G HOLDEN S KHANDEKAR V CHEN YN
Citation: Ba. Teicher et al., BETA-CYCLODEXTRIN TETRADECASULFATE TETRAHYDROCORTISOL PLUS-OR-MINUS MINOCYCLINE AS MODULATORS OF CANCER THERAPIES IN-VITRO AND IN-VIVO AGAINST PRIMARY AND METASTATIC LEWIS LUNG-CARCINOMA, Cancer chemotherapy and pharmacology, 33(3), 1993, pp. 229-238

Authors: PUREWAL M LIEHR JG
Citation: M. Purewal et Jg. Liehr, COVALENT MODIFICATION OF DNA BY DAUNORUBICIN, Cancer chemotherapy and pharmacology, 33(3), 1993, pp. 239-244

Authors: PEREZ EA HACK FM WEBBER LM CHOU TC
Citation: Ea. Perez et al., SCHEDULE-DEPENDENT SYNERGISM OF EDATREXATE AND CISPLATIN IN COMBINATION IN THE A549 LUNG-CANCER CELL-LINE AS ASSESSED BY MEDIAN-EFFECT ANALYSIS, Cancer chemotherapy and pharmacology, 33(3), 1993, pp. 245-250

Authors: CURLEY SA STONE DL FUHRMAN GM HOHN DC SIDDIK ZH NEWMAN RA
Citation: Sa. Curley et al., INCREASED DOXORUBICIN LEVELS IN HEPATIC-TUMORS WITH REDUCED SYSTEMIC DRUG EXPOSURE ACHIEVED WITH COMPLETE HEPATIC VENOUS ISOLATION AND EXTRACORPOREAL CHEMOFILTRATION, Cancer chemotherapy and pharmacology, 33(3), 1993, pp. 251-257

Authors: BONETTI A KIM S
Citation: A. Bonetti et S. Kim, PHARMACOKINETICS OF AN EXTENDED-RELEASE HUMAN INTERFERON-ALPHA-2B FORMULATION, Cancer chemotherapy and pharmacology, 33(3), 1993, pp. 258-261

Authors: KOVACS GT PAAL C SOMLO P KOOS R SCHULER D BORSI JD
Citation: Gt. Kovacs et al., PROTEINURIA DUE TO SUBOPTIMAL HYDRATION WITH HIGH-DOSE METHOTREXATE THERAPY, Cancer chemotherapy and pharmacology, 33(3), 1993, pp. 262-263

Authors: TRESKES M VANDERVIJGH WJF
Citation: M. Treskes et Wjf. Vandervijgh, WR2721 AS A MODULATOR OF CISPLATIN-INDUCED AND CARBOPLATIN-INDUCED SIDE-EFFECTS IN COMPARISON WITH OTHER CHEMOPROTECTIVE AGENTS - A MOLECULAR APPROACH, Cancer chemotherapy and pharmacology, 33(2), 1993, pp. 93-106

Authors: CONLEY BA EGORIN MJ WHITACRE MY CARTER DC ZUHOWSKI EG VANECHO DA
Citation: Ba. Conley et al., PHASE-1 AND PHARMACOKINETIC TRIAL OF LIPOSOME-ENCAPSULATED DOXORUBICIN, Cancer chemotherapy and pharmacology, 33(2), 1993, pp. 107-112

Authors: FREI E HOLDEN SA GONIN R WAXMAN DJ TEICHER BA
Citation: E. Frei et al., ANTITUMOR ALKYLATING-AGENTS - IN-VITRO CROSS-RESISTANCE AND COLLATERAL SENSITIVITY STUDIES, Cancer chemotherapy and pharmacology, 33(2), 1993, pp. 113-122

Authors: ZALCBERG JR HU XF CHING M WAKELING A WALL DM MARSCHNER IC DELUISE M
Citation: Jr. Zalcberg et al., DIFFERENTIAL-EFFECTS OF ESTROGEN, TAMOXIFEN AND THE PURE ANTIESTROGENICI-182,780 IN HUMAN DRUG-RESISTANT LEUKEMIA-CELL LINES, Cancer chemotherapy and pharmacology, 33(2), 1993, pp. 123-129

Authors: QURESHI S ALHARBI MM AHMED MM RAZA M GIANGRECO AB SHAH AH
Citation: S. Qureshi et al., EVALUATION OF THE GENOTOXIC, CYTOTOXIC, AND ANTITUMOR PROPERTIES OF COMMIPHORA MOLMOL USING NORMAL AND EHRLICH ASCITES-CARCINOMA CELL-BEARING SWISS ALBINO MICE, Cancer chemotherapy and pharmacology, 33(2), 1993, pp. 130-138

Authors: SMITH DC VAUGHAN WP GWILT PR TRUMP DL
Citation: Dc. Smith et al., A PHASE-I TRIAL OF HIGH-DOSE CONTINUOUS-INFUSION HYDROXYUREA, Cancer chemotherapy and pharmacology, 33(2), 1993, pp. 139-143

Authors: KLEEBERGER L ROTTINGER EM
Citation: L. Kleeberger et Em. Rottinger, EFFECT OF PH AND MODERATE HYPERTHERMIA ON DOXORUBICIN, EPIRUBICIN ANDACLACINOMYCIN-A CYTOTOXICITY FOR CHINESE-HAMSTER OVARY CELLS, Cancer chemotherapy and pharmacology, 33(2), 1993, pp. 144-148

Authors: WILKOFF LJ DULMADGE EA VASANTHAKUMAR G DONAHUE JP
Citation: Lj. Wilkoff et al., ETOPOSIDE-RESISTANT HUMAN COLON AND LUNG ADENOCARCINOMA CELL-LINES EXHIBIT SENSITIVITY TO HOMOHARRINGTONINE, Cancer chemotherapy and pharmacology, 33(2), 1993, pp. 149-153

Authors: SAITO H SHIMOKATA K SAKA H YAMAMOTO M OGASAWARA T NOMURA F SAKAI S IWATA M MURATE T MIYACHI T NAKASHIMA K SAITO H
Citation: H. Saito et al., PHASE-II STUDY OF CARBOPLATIN, CISPLATIN, AND VINDESINE IN ADVANCED NON-SMALL-CELL LUNG-CANCER, Cancer chemotherapy and pharmacology, 33(2), 1993, pp. 154-156

Authors: CHEN G ZELLER WJ
Citation: G. Chen et Wj. Zeller, REVERSAL OF ACQUIRED CISPLATIN RESISTANCE BY NICOTINAMIDE IN-VITRO AND IN-VIVO, Cancer chemotherapy and pharmacology, 33(2), 1993, pp. 157-162

Authors: BARBERIHEYOB M GRIFFON G MERLIN JL WEBER B
Citation: M. Barberiheyob et al., SEQUENCE-DEPENDENT GROWTH-INHIBITORY EFFECTS OF THE IN-VITRO COMBINATION OF FLUOROURACIL, CISPLATIN, AND DIPYRIDAMOLE, Cancer chemotherapy and pharmacology, 33(2), 1993, pp. 163-170
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>